Slide showing the Next Generation DX Summit logo and the individuals participating in the Business of Diagnostics and Future Outlook panel

Monday August 24, 2026 – Wednesday August 26, 2026
18th Annual Next Generation DX Summit

Plenary Fireside Chat: Business of Diagnostics and Future Outlook
Discussing recent significant transactions in the diagnostics sector, and address what we see as the near and longer term impact on the field, along with the policy & business outlook.

Christine C. Ginocchio, PhD, MT (ASCP)
Chief Medical Officer, Qiagen

Taylor Jensen, PhD
Vice President, Head of Science, Oncology, Labcorp

Ipsita Smolinski, MBA
Founder/Managing Director, Capitol Street
Faculty, Georgetown University

Elissa Quinn
Medical Director, Cancer Screening & Early Detection, AstraZeneca

Daryl Pritchard, PhD – Moderator
Senior Vice President, Science Policy, Personalized Medicine Coalition